772 related articles for article (PubMed ID: 31700067)
21. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
22. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
23. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
24. Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs.
Chen H; Han Z; Su J; Song X; Ma Q; Lin Y; Ran Z; Li X; Mou R; Wang Y; Li D
Front Immunol; 2024; 15():1424954. PubMed ID: 38846953
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
Tang SJ; Yang JB
Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
[TBL] [Abstract][Full Text] [Related]
26. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
[TBL] [Abstract][Full Text] [Related]
27. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
29. N
Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
31. The long noncoding RNA
Pan W; Zhang N; Liu W; Liu J; Zhou L; Liu Y; Yang M
J Biol Chem; 2018 Nov; 293(44):17154-17165. PubMed ID: 30228180
[TBL] [Abstract][Full Text] [Related]
32. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
Lin X; Yang S
Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
[TBL] [Abstract][Full Text] [Related]
33. Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma.
Zhang L; He T; Yan Y; Zhang Y; Zhou X; Huang P; Kong Y; Xie M; Zhang L; Sun Q; Zhou D; Xie H; Zhou L; Zheng S; Wang W
Biomed Res Int; 2016; 2016():3608914. PubMed ID: 27896271
[TBL] [Abstract][Full Text] [Related]
34. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
Liu Y; Geng X
Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
[TBL] [Abstract][Full Text] [Related]
36. Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells.
Shang Y; Luo M; Yao F; Wang S; Yuan Z; Yang Y
Cell Signal; 2020 Aug; 72():109633. PubMed ID: 32283255
[TBL] [Abstract][Full Text] [Related]
37. lncRNA RMRP knockdown suppress hepatocellular carcinoma biological activities via regulation miRNA-206/TACR1.
Hongfeng Z; Andong J; Liwen S; Mingping B; Xiaowei Y; Mingyong L; Aimin Y
J Cell Biochem; 2020 Feb; 121(2):1690-1702. PubMed ID: 31579977
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA RP11-909N17.2 promotes proliferation, invasion, and migration of hepatocellular carcinoma by regulating microRNA-767-3p.
Liu Q; Dai SJ; Dong L; Li H
Biochem Cell Biol; 2020 Dec; 98(6):709-718. PubMed ID: 33210543
[TBL] [Abstract][Full Text] [Related]
40. Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.
Wang J; Zhang Y; Lu L; Lu Y; Tang Q; Pu J
J Cell Biochem; 2019 Nov; 120(11):18816-18825. PubMed ID: 31297882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]